Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

Autor: Adrian P.M. Kormann, Maicon Falavigna, Vicente C.S. Dantas, Pedro Gabriel Melo de Barros e Silva, Leandro S. Echenique, Ary Serpa-Neto, Conrado R. Hoffmann Filho, Nicole A. Golin, Luciano Cesar Pontes Azevedo, Renato D. Lopes, Lucas P. Damiani, Lígia Nasi Laranjeira, Eveline P. Milan, Erlon Oliveira de Abreu-Silva, Fábio F. Cardoso, Aline T. Soares, Alvaro Avezum, Regis Goulart Rosa, Otavio Berwanger, Flávio Geraldo Resende Freitas, Viviane C Veiga, Aline Marcadenti, Otavio Gebara, Adriano José Pereira, Alexandre Biasi Cavalcanti, Monalisa Fernanda Bocchi de Oliveira, Remo H.M. Furtado, Roberto Bleuel Amazonas, Fernando G. Zampieri, Flávia Ribeiro Machado, Israel Silva Maia, Lucas Tramujas, Leticia Kawano-Dourado, Debora L. M. Junqueira, Thiago Lisboa

Publikováno v: The New England Journal of Medicine
Repositório Institucional do Centro Universitário La Salle
Universidade La Salle (UNILASALLE)
instacron:UNILASALLE
New England Journal of Medicine
New England journal of medicine, 383(21), 2041-2052. Massachussetts Medical Society

Submitted by DSpace Unilasalle (dspace@unilasalle.edu.br) on 2021-07-30T17:29:03Z No. of bitstreams: 1 Hydroxychloroquine with or without Azithromycin_NEJM.pdf: 657905 bytes, checksum: abd774ed0fca84d1bf82fc915cc48491 (MD5) Made available in DSpace o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3303b681c28175559c9c56a0ebcf1679
http://europepmc.org/articles/PMC7397242